Ameliorative Effect of Hydroethanolic Leaf Extract of Byrsocarpus coccineus in Alcohol- and Sucrose-Induced Hypertension in Rats

10.4103/2225-4110.129562

Abidemi J. Akindele；Endurance A. Iyamu；Prabhu Dutt；Naresh K. Satti；Olufunmilayo O. Adeyemi

Alcohol ； Antioxidant ； Byrsocarpus coccineus ； Connaraceae ； Hypertension ； Sucrose

Journal of Traditional and Complementary Medicine

4卷3期（2014 / 07 / 01）

177 - 188

英文

Hypertension remains a major health problem worldwide considering the prevalence of morbidity and mortality. Plants remain a reliable source of efficacious and better tolerated drugs and botanicals. This study was designed to investigate the effect of the chemo-profiled hydroethanolic leaf extract of Byrsocarpus coccineus in ethanol- and sucrose-induced hypertension. Groups of rats were treated orally (p.o.) with distilled water (10 ml/kg), ethanol (35%; 3 g/kg), sucrose (5-7%), and B. coccineus (100, 200, and 400 mg/kg), and nifedipine together with ethanol and sucrose separately for 8 weeks. At the end of the treatment period, blood pressure and heart rate of rats were determined. Blood was collected for serum biochemical parameters and lipid profile assessment, and the liver, aorta, kidney, and heart were harvested for estimation of in vivo antioxidants and malondialdehyde (MDA). Results obtained in this study showed that B. coccineus at the various doses administered reduced the systolic, diastolic, and arterial blood pressure elevated by ethanol and sucrose. Also, the extract reversed the reduction in catalase (CAT), reduced glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD) induced by ethanol and sucrose. The level of MDA was reduced compared to the ethanol- and sucrose-induced hypertensive group. With respect to lipid profile, administration of B. coccineus at the various doses reduced the levels of triglycerides, low-density lipoprotein (LDL), cholesterol, and atherogenic indices, compared to the ethanol and sucrose groups. In conclusion the hydroethanolic leaf extract of B. coccineus exerted significant antihypertensive effect and this is probably related to the antioxidant property and improvement of lipid profile observed in this study.

1. (2002).World Health Report. Reducing risks, promoting healthy life.Geneva:World Health Organization.
2. Adeneye, AA,Adeleke, TI,Adeneye, AK(2008).Hypoglycemic effects of Clerodendrum capitatum in Wister rats.J Ethnopharmacol,116,7-10.
3. Ahmadu, AA,Akpulu, IN,Hassan, HS,Sule, MI,Pateh, UU(2006).Preliminary phytochemical and antimicrobial screening of the leaves of Byrsocarpus coccineus Schum and Thonn. (Connaraceae).J Pharm Bioresourc,3,107-110.
4. Ahmadu, AA,Akpulu, IN,Hassan, HS,Sule, MI,Pateh, UU(2006).Antibacterial and anti‑inflammatory activity of Byrsocarpus coccineus and its constituents.Planta Med,72,203.
5. Akindele, AJ,Adeyemi, OO(2007).Anti‑inflammatory activity of the aqueous leaf extracts of Byrsocarpus coccineus.Fitoterapia,78,25-28.
6. Akindele, AJ,Eksioglu, EA,Kwan, JC,Adeyemi, OO,Liu, C,Luesch, H(2011).Biological Effects of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae) in vitro.Pharm Biol,49,152-160.
7. Akindele, AJ,Ezenwanebe, KO,Anunobi, CC,Adeyemi, OO(2010).Hepatoprotective and in vivo antioxidant effects of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae).J Ethnopharmacol,129,46-52.
8. Amos, S,Binda, L,Kunle, OF,Wambebe, C,Gamaniel, K(2002).Uterotonic properties of the ethanolic extract of Byrsocarpus coccineus.Pharm Biol,40,33-38.
9. Ayensu, ES(1978).Medicinal plants of West Africa.Michigan:Reference Publications Inc., Algonac.
10. Bilanda, DC,Dimo, T,Djomeni, PD,Bella, NM,Aboubakar, OB,Nguelefack, TB(2010).Antihypertensive and antioxidant effects of Allanblackia floribunda Oliv. (Clusiaceae) aqueous extract in alcohol‑ and sucrose‑induced hypertensive rats.J Ethnopharmacol,128,634-640.
11. Bunag, RD,Tomita, T,Sazaki, S(1983).Chronic sucrose ingestion induces mild hypertension and tachycardia in rat.Hypertension,5,218-225.
12. Burkill, HM.(1985).The useful plants of west tropical Africa.Kew:Royal Botanic Gardens.
13. Ceyhun Sezgin, AE,Artık, N(2010).Determination of saponin content in Turkish Tahini Halvah by using HPLC.Adv J Food Sci Technol,2,109-115.
14. Chockalingam, A(2008).World Hypertension Day and global awareness.Can J Cardiol,24,441-444.
15. Chockalingam, A,Balaguer‑Vintro, I,Achutti, A,de Luna, AB,Chalmers, J,Farinaro, E(2000).The World Heart Federation’s white book: Impending global pandemic of cardiovascular diseases: Challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition.Can J Cardiol,16,227-279.
16. Chockalingam, A,Campbell, NR,Fodor, JG(2006).Worldwide epidemic of hypertension.Can J Cardiol,22,553-555.
17. Clarke, EG,Clarke, ML(1977).Veterinary Toxicology.London:Cassel and Collier Macmillan Publishers.
18. Committee for the Update of the Guide for the Care and Use of Laboratory Animals(2011).Guide for the Care and Use of Laboratory Animals National Academy of Sciences.Washington DC:National Academies Press.
19. Dalziel, JM,Hutchinson, J.(1955).Useful plants of West Africa.London:Crown Agents for Oversea Publication.
20. Edeoga, HO,Okwu, DE,Mbaebie, BO(2005).Phytochemical constituents of some Nigerian medicinal plants.Afr J Biotechnol,4,685-688.
21. Egert, S,Bosy‑Westphal, A,Seiberl, J,Kürbitz, C,Settler, U,Plachta‑Danielzik, S(2009).Quercetin reduces systolic blood pressure and plasma oxidised low‑density lipoprotein concentrations in overweight subjects with a high‑cardiovascular disease risk phenotype: A double‑blinded, placebo‑controlled cross‑over study.Br J Nutr,102,1065-1074.
22. Estruch, R,Coca, A,Rodicio, JL(2005).High blood pressure, alcohol and cardiovascular risk.J Hypertens,23,226-229.
23. Ezzati, M,Lopez, AD,Rodgers, A,Vander Hoorn, S,Murray, CJ,Comparative Risk Assessment Collaborating Group(2002).Selected major risk factors and global regional burden of disease.Lancet,360,1347-1360.
24. Flack, JM(1994).High blood pressure in older persons: A high risk special population.Can J Public Health,85(Suppl 2),S9-S11.
25. Fodor, JG,Leenen, FH,Helis, E,Turton, P(2008).2006 Ontario Survey on the Prevalence and Control of Hypertension (ON‑BP): Rationale and design of a community‑based cross‑sectional survey.Can J Cardiol,24,503-505.
26. Girard, A,Sihem, M,Boukortt, F,Cherkaoui‑Malki, M,Belleville, J,Prost, J(2006).Fructose‑enriched diet modifies antioxidant status and lipid metabolism in spontaneous hypertensive rats.Nutrition,22,758-766.
27. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177:751‑66.
28. Greenstein, B,Greenstein, A.(2007).Concise Clinical Pharmacology.London:Pharmaceutical Press.
29. Hartwell, JL(1968).Plants used against cancer. A survey.Lloydia,31,71-170.
30. Husain, K,Mejia, J,Lalla, J,Kasim, S(2005).Dose response of alcohol induced changes in BP, nitric oxide and antioxidants in rat plasma.Pharmacol Res,51,337-343.
31. Hypertension Detection and Follow‑up Program Cooperative Group(1982).The effect of treatment on mortality in ‘mild’ hypertension: Results of the Hypertension Detection and Follow‑up Program.N Engl J Med,307,976-980.
32. Ikewuchi, CC(2012).Hypocholesterolemic effect of an aqueous extract of the leaves of Sansevieria senegambica baker on plasma lipid profile and atherogenic indices of rats fed egg yolk supplemented diet.EXCLI J,11,318-327.
33. Johnson, RJ,Segal, MS,Sautin, Y,Nakagawa, T,Feig, DI,Kang, DH(2007).Potential role of sugar fructose in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.Am J Clin Nutr,86,899-906.
34. Kasdallah‑Grissa, A,Mornagui, B,Aouani, E,Hammani, M,Gharbi, N,Kamoun, A(2006).Protective effect of resveratrol on ethanol‑induced lipid peroxidation in rats.Alcohol Alcohol,41,236-239.
35. Kearney, PM,Whelton, M,Reynolds, K,Muntner, P,Whelton, PK,He, J(2005).Global burden of hypertension: Analysis of worldwide data.Lancet,365,217-223.
36. Martirosyan, DM,Miroshnichenko, LA,Kulokawa, SN,Pogojeva, AV,Zoloedov, VI(2007).Amaranth oil application for heart disease and hypertension.Lipids Health Dis,6,1.
37. Oke, JM,Hamburger, MO(2002).Screening of some Nigerian medicinal plants for antioxidant activity using 2,2, Diphenyl‑picryl‑hydrazyl radical.Afr J Biomed Res,5,77-79.
38. Okunji, CO,Iwu, MM(1988).Control of Schistosomiasis using Nigerian Medicinal plants as molluscicides.Int J Crude Drug Res,26,246-252.
39. Panchal, SK,Poudyal, H,Arumugam, TV,Brown, L(2011).Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high‑carbohydrate, high‑fat diet‑fed rats.J Nutr,141,1062-1069.
40. Parik, T,Alliknets, K,Teesalu, R,Zilmer, M(1996).Oxidative stress and hyperinsulinaemia in essential hypertension: Different facets of increased risk.J Hypertens,14,407-410.
41. Pater, C(2005).Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement – is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I).Curr Control Trials Cardiovasc Med,6,6.
42. Randhawa, MA(2009).Calculation of LD50 values from the method of Miller and Tainter, 1944.J Ayub Med Coll Abbottabad,21,184-185.
43. Resstel, LB,Tirapelli, CR,Lanchote, VL,Uyemura, SA,de Oliveira, AM,Correa, FM(2005).Chronic ethanol consumption alters cardiovascular functions in conscious rats.Life Sci,78,2179-2187.
44. Soon, YY,Tan, BK(2002).Evaluation of the hypoglycaemic and antioxidant activities of Morinda officinalis in streptosozin‑induced diabetic rats.Singapore Med J,43,77-85.
45. Stevens, RJ,Coleman, RL,Shine, BL,Holman, RR(2004).Could non‑HDL cholesterol replace total/HDL cholesterol ratio to estimate coronary heart disease risk in the UKPDS risk engine?.Diabetologia,47(Suppl 1),A61.
46. Sudheesh, S,Manilal, VB,Vijayalakshmi, NR(2005).Potential health promoting effects of flavonoids: A comparative study on hypolipidaemic and hypoglycaemic activities.Proceedings of the 53rd Annual Meeting of the Society of Medicinal Plant Research (GA) and Joint Congress with the Italian Society of Phytochemistry (SIF),Florence, Italy:
47. Suzuki, A,Yamamoto, N,Jokura, H,Yamamoto, M,Fujii, A,Tokimitsu, I(2006).Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats.J Hypertens,24,1065-1073.
48. Topping, DL,Storer, GB,Calvert, GG(1980).Effects of dietary saponins on faecal bile acids and neutral sterols, plasma lipid and lipid turnover in the pig.Am J Clin Nutr,33,783-786.
49. Touyz, RM,Campbell, N,Logan, A,Gledhill, N,Petrella, R,Padwal, R,Canadian Hypertension Education Program(2004).The 2004 Canadian recommendations for the management of hypertension: Part III – Lifestyle modifications to prevent and control hypertension.Can J Cardiol,20,55-59.
50. Vasdev, S,Sampson, CA,Prabhakaran, VM(1991).Platelet‑free calcium and vascular calcium uptake in ethanol‑induced hypertensive rats.Hypertension,18,116-122.
51. Whelton, PK(1994).Epidemiology of hypertension.Lancet,344,101-106.
52. Whelton, PK,He, J,Muntner, P(2004).Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia.J Hum Hypertens,18,545-551.